Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125539 · ClinicalTrials.gov registry record · Phase 2
Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment
A Phase 2 study, sponsored by Inflexxion.
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT02125539 is a Phase 2 study that has completed, run by Inflexxion. The registered enrollment target is 160 participants.
The verdict
NCT02125539, a Phase 2 study, has completed, sponsored by Inflexxion.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to provide a comprehensive evaluation of the new, Navigating my Journey program for adolescents receiving treatment in an outpatient substance abuse center. The primary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with significantly higher motivation, higher self-efficacy, improved relapse coping skills, and lower substance use. The secondary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with increased therapeutic alliances with counselors.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Navigating my Journey program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02125539
The ClinicalTrials.gov registry entry for NCT02125539 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inflexxion, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT02125539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02125539 about?
NCT02125539 is a clinical study titled "Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment". The purpose of this study is to provide a comprehensive evaluation of the new, Navigating my Journey program for adolescents receiving treatment in an outpatient substance abuse center. The primary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with...
What is the current status of trial NCT02125539?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2014-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02125539?
The interventions under investigation include: Attention Control (BEHAVIORAL), Navigating my Journey program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02125539?
This trial is sponsored by Inflexxion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.